Trial
NCT03219372
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Cedars-Sinai Medical Center
Collaborators
National Institutes of Health (NIH); National Cancer Institute (NCI)
Condition
Hepatocellular Carcinoma
Intervention
Pravastatin Pill
Why stopped
Study discontinued due to low accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-22